CTA approval

Durham, North Carolina, U.S. | April 15, 2026 Precision BioSciences has announced a significant clinical and regulatory milestone with...

MILAN, Italy, Oct. 2, 2025 — AAVantgarde Bio announced that its investigational gene therapy AAVB-039 has received Orphan Drug...